Diversified Nano Solutions Corp. and Screen Graphic Solutions Co., Ltd. Enter into a Strategic Relationship to Offer Revolutionary INKcrypt® DNA-Identity Ink and x-nano™ Special Effect Inkjet Inks for Screen Inkjet Platforms
Diversified Nano Solutions Corporation (DNSC) and Screen Graphic Solutions Co, Ltd. (Screen) announce a strategic cooperation to offer revolutionary INKcrypt® anti-counterfeit solutions and x-nano™ special effect digital inkjet inks for Screen inkjet platforms. At PRINT17, Screen will demonstrate DNSC inkjet solutions (MICR and invisible UV fluorescent inks) with Truepress Jet520NX at booth 2613, September 10-14, 2017, in Chicago.
DNSC specializes in developing and manufacturing security ink, high-performance black & color ink, MICR ink, special effect inks, and associated fluids for digital printing platforms, which complements Screen’s focus on developing, manufacturing and marketing best-in-class Inkjet presses to clients worldwide.
“Our strategic cooperation with DNSC will allow Screen accelerated expansion and penetration of existing and new market opportunities for its portfolio of high performance digital inkjet platforms in particular related to graphics, security, finance (MICR), transpromo, and a fast growing demand in anti-counterfeit solutions,” said Seiichi Nakao, Global Business Director of Continuous HSI printers. “Screen’s family of Truepress Jet520 HD, ZZ, EX and NX, high speed, mono and high resolution full color inkjet presses are ideally positioned to support any market demand most competitively. In addition to conventional ink variations, we will be able to strongly promote the expansion of applications of inkjet presses.”
Bruce Carnes, Director of Business Development, added, “We are pleased with our opportunity to collaborate with Screen, a leading inkjet system manufacturer and famous brand in the industry, to jointly bring new inkjet output possibilities to users worldwide.”
Ideally suited for Screen inkjet platforms and a patent-pending industry innovation is DNSC’s revolutionary INKcrypt® technology, which integrates with inkjet and other fluid dispensing platforms. Users are now able to distinguish documents and/or products based on unique ink-identity, which can be authenticated on the spot using www.inkcryptink.com and smart devices. INKcrypt® provides item tracing, complete supply chain transparency, and elimination of fraud and counterfeiting. The INKcrypt® technology is based on unique DNA-identity markers, customized for each user, which can be added without changing the ink’s or fluid’s physical properties. INKcrypt® protects consumers and businesses from fraud, complete theft of product value, and health risks associated with counterfeiting, while brand owners prevent loss and strengthen customer confidence and loyalty.
Screen’s inkjet systems will be fully INKcrypt® compliant and support DNSC’s x-nano™ ink portfolio, including:
MICR ink (K-Ink Series), invisible UV fluorescent color, infrared-absorbing (I-Ink Series), and special inks. DNSC inks, customized for Screen systems, will be available through Screen’s sales channels worldwide. Screen and DNSC jointly are ideally positioned to help users create differentiated, high-value output through personalization using x-nano™ special effect inks such as magnetic (MICR), invisible fluorescent and security inks for digital inkjet platforms.
SCREEN Graphic Solutions Co., Ltd. (SCREEN GA) is a core group company of SCREEN Holdings Co., Ltd. (formerly Dainippon Screen Mfg. Co., Ltd.) and is also one of the world’s leading manufacturers of graphic arts equipment. SCREEN GA has utilized the image processing and inkjet technologies developed by the SCREEN Group over many decades to create the Truepress Jet series of inkjet POD presses, which includes roll-fed, UV label, large size and sheet-fed systems. The comprehensive lineup also features market-leading products such as EQUIOS universal workflow and the PlateRite series of CtP devices.
Diversified Nano Solutions Corporation (DNSC), based in San Diego, California, specializes in developing and manufacturing nano materials and fluids used in high-performance functional inks for digital printing, unique customer applications, research and surface treatments. DNSC has developed an extensive product line of inks known as x-nano™, providing a range of solutions that utilize nanoparticles in long-term stable suspension, including MICR inks (Magnetic Ink Character Recognition), invisible color (RGB) fluorescent inks (UV [250-365nm] / IR [780-1050nm]), special pigmented/hybrid inks, and special pigmented/hybrid inks for food grade and non-food applications. These digital inks address drop-on-demand inkjet applications based on thermal and piezo print heads using aqueous, oil, energy curable (UV/LED) and eco-solvent-based inks. The company maintains high volume manufacturing facilities in Europe and the USA. DNSC’s inks are suitable for systems and platforms offered by various inkjet printer vendors and inkjet head manufacturers.
DNSC will be presenting INKcrypt® inks and its line of black & color, magnetic, invisible, special effect, and security inks for the world’s leading inkjet print systems in the desktop, commercial and industrial inkjet space.
Visit booth 854 and discover DNSC digital INKS unlimited!
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
BearingPoint: How Firms Transform into Digital Superpowers22.2.2018 11:30 | Tiedote
Digital disruption has left Europe’s leading companies struggling to sustain growth and competitive advantage. Groundbreaking new research reveals how European companies can learn from US digital superpowers to speed up adoption of business model innovation, drive new revenues and get greater value from their core business. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180222005241/en/ Diversifying business model Portfolio (Graphic: Business Wire) Today, firms that adopt a portfolio of business models which are asset light and include network effects are perceived by investors and the market as most likely to generate future growth. They therefore have a much higher market value in comparison to companies with traditional business models. Companies who diversified their business models improved their valuation in 2016 by 65% in comparison to those who maintained a mono-business model. Furthermore, between 2011-2016 they mana
Eli Global to Acquire Lead Generation Marketplace Finanzen22.2.2018 11:00 | Tiedote
Eli Global LLC (“Eli”) today announced that an affiliate has entered into a definitive agreement to acquire finanzen.de AG and its subsidiaries (collectively, “Finanzen” or the “company”) from Blackfin Capital Partners (“Blackfin”) and Finanzen’s founders. Based in Berlin, Germany, Finanzen is the leading European online marketplace for retail customer leads in the finance and insurance sectors. The company connects lead generators such as online price comparison sites with lead buyers such as independent financial advisors and insurance agents. The company also acts as an online broker for certain insurance products. “Finanzen has done an impressive job creating a scalable technology platform poised to benefit from industry trends,” said George Luecke, global manager of Eli’s newly established insurance services portfolio and co-CEO of Global Bankers Insurance Group, which represents Eli’s life and annuity carrier division (“GBIG”). “We look forward to a long-term future with the comp
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage22.2.2018 09:00 | Tiedote
Ferring Pharmaceuticals and MSD, known as Merck & Co., Inc., Kenilworth, N.J., U.S.A., through its MSD for Mothers initiative, today announced the completion of CHAMPION (Carbetocin Haemorrhage Prevention), a global clinical trial conducted by the Human Reproduction Program (HRP) at the World Health Organization (WHO). CHAMPION is investigating whether Ferring’s proprietary and heat-stable carbetocin could offer a new solution to prevent excessive bleeding after childbirth (postpartum haemorrhage or PPH).2,3 Involving nearly 30,000 women in 10 countries, it is the largest clinical trial ever conducted in PPH.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221006496/en/ Each year, 14 million mothers are affected by PPH.4 As the leading direct cause of maternal mortality, 480,000 mothers died from PPH between 2003-09.1 Even when women survive, PPH can result in the need for serious medical interventions, including surgica
The Nippon Foundation: Project to Map Ocean Floor by 2030 Now Operational22.2.2018 08:00 | Tiedote
The Nippon Foundation Chairman Yohei Sasakawa announced at a press conference today that The Nippon Foundation – GEBCO Seabed 2030 Project is now operational. The Project will realize Mr. Sasakawa’s vision of mapping the entire ocean floor by 2030. The Nippon Foundation has pledged US$2 million annually, and is calling for additional support from the global ocean community. Mr. Sasakawa noted, “The Nippon Foundation alone cannot achieve the objectives of this ambitious project. We will need the support of diverse stakeholders, including maritime corporations and technical experts. It is crucial that the ocean community comes together to achieve this goal”. He was joined by leading ocean-mapping experts, who emphasized that understanding the bathymetry of the global ocean is imperative for improving maritime navigation, and also for enhancing our ability to predict climate change and monitor marine biodiversity and resources. A comprehensive map of the seafloor will assist global effort
Vertex Initiates First Phase 3 Study of VX-659, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis22.2.2018 00:01 | Tiedote
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it is initiating the first Phase 3 study of VX-659, tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis (CF) who have one F508del mutation and one minimal function mutation. The study will enroll 360 patients, and the primary endpoint of the study is the mean absolute change from baseline in percent predicted forced expiratory volume in one second (ppFEV1) at week four of treatment. The study is designed to support the submission of a New Drug Application (NDA) in the U.S. using data from the 4-week primary efficacy endpoint together with safety data through 12 weeks of treatment. “Our goal is to bring the best triple combination to patients as rapidly as possible, and this first Phase 3 study of VX-659 in combination with tezacaftor and ivacaftor is a significant step toward that goal,” said Jeffrey Chodakewitz, M.D., Executive Vice President and Chief Medical
Universal Laser Systems® Expands Portfolio of Laser Material Processing Systems with the ULTRA Platform Series21.2.2018 21:00 | Tiedote
ULTRA platform-based laser systems are designed and ideally suited for precision laser cutting, laser ablation, and laser surface modification in manufacturing, research and development, academic research and prototyping environments. Major features of the series include rapid, high-accuracy laser beam positioning, and the flexibility to be configured with 9.3 and 10.6 µm CO2 lasers and 1.06 µm fiber lasers. All lasers are air-cooled in a range of power from 10 to 150 watts for CO2 and 40 to 50 watts for fiber lasers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221005364/en/ The ULTRA 9MW offers MultiWave processing of thin materials. (Photo: Business Wire) The variety of wavelengths and power ranges make the ULTRA platforms highly effective in the areas of organic material modification, including plastic films, industrial fabrics, engineering plastics, laminating adhesives, composite materials, and many others utilized
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme